CXCL12 and neurodegenerative disease: SDF‐1 not only enhances GABA and glutamate activities of 5‐hydroxytryptamine neurons, but also enhances the proliferation and migration of neuronal stem cells, and the damage of these mechanisms has been proved to be associated with neurodegenerative diseases.